Cardiovascular-kidney-metabolic stage improvement

Cardiovascular-kidney-metabolic stage improvement has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest paper, Jun 12, 2026: “Stage-Specific Progression of Cardiovascular-Kidney-Metabolic Health and Mortality in a Nationwide Cohort of East Asian Adults”.

Exposure

1 paper studies it1 findingUpdated

See all 1 papers on cardiovascular-kidney-metabolic stage improvement

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“whereas CKM stage improvement was associated with a lower risk (adjusted HR, 0.93 [0.90 to 0.95])”
Stage-Specific Progression of Cardiovascular-Kidney-Metabolic Health and Mortality in a Nationwide Cohort of East Asian AdultsClinical journal of the American Society of Nephrology : CJASN2026doi:10.2215/cjn.0000001104
Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Funders: Korea Health Industry Development Institute and 2 more
  • Humans1

What is cardiovascular-kidney-metabolic stage improvement linked with?

1

Studies link cardiovascular-kidney-metabolic stage improvement with 1 measure, most often mortality (1 study).

Mortality

downin humans1

1 study
  1. Cardiovascular-kidney-metabolic stage improvement is linked with a lower risk of mortality in humans (adjusted for clinicodemographic variables).

    “whereas CKM stage improvement was associated with a lower risk (adjusted HR, 0.93 [0.90 to 0.95])”

    Humansadjusted for clinicodemographic variables6.4-year follow-up

    Stage-Specific Progression of Cardiovascular-Kidney-Metabolic Health and Mortality in a Nationwide Cohort of East Asian Adults

    Clinical journal of the American Society of Nephrology : CJASN

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months